SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-15-000504
Filing Date
2015-06-19
Accepted
2015-06-19 11:09:29
Documents
1
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4063
  Complete submission text file 0001562180-15-000504.txt   5460
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AILERON THERAPEUTICS INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Yanchik Joseph A., III (Reporting) CIK: 0001618154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 15941647